Impact of nonalcoholic fatty liver disease status change on antiviral efficacy of nucleos(t)ide analogues in HBeAg-positive chronic hepatitis B.
Tang Y, Fan R, Lan Z, Xie Q, Zhang J, Liang X, Wang H, Tan D, Cheng J, Chen S, Ning Q, Bai X, Xu M, Chen X, Niu J, Shi J, Ren H, Gao Z, Wang M, Dou X, Hou J, Sun J.
Tang Y, et al. Among authors: lan z.
J Med Virol. 2023 Feb;95(2):e28501. doi: 10.1002/jmv.28501.
J Med Virol. 2023.
PMID: 36655747
Clinical Trial.